Impact of Fluid Status on Liver Elastography and T1-mapping Results in Patients Undergoing CMR.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05239260

Enrollment

150

Registered

2022-02-14

Start date

2022-02-01

Completion date

2023-01-01

Last updated

2022-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CMR, Liver Fibrosis, NAFLD/MAFLD

Keywords

NAFLD, CMR

Brief summary

Correlation between CMR T1-times, liver T1-times, fibroscan and fluid status to identify the correlation and pathogenesis of liver disease in patients with heart disease.

Interventions

DIAGNOSTIC_TESTCMR

CMR

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

* Referred for Cardiovascular Magnetic Resonance Imaging

Exclusion criteria

* Non-compatible Devices

Design outcomes

Primary

Measure	Time frame
Impact of fluid status on liver elastography and T1-times	5 months

Countries

Austria

Contacts

Primary ContactKatharina Mascherbauer

katharina.mascherbauer@meduniwien.ac.at0043 1 40400 48590

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026